A comprehensive view of F. Hoffmann-La Roche Ltd. (Roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
F Hoffmann-La Roche AG Files Patent Application for Method and System for Automated Activity Recommendation in Diabetes Treatment Plans
Published:
May 20, 2024
by Indian Patents News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "ANTIBODIES BINDING TO HLA-A*02/FOXP3"
Published:
May 19, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "TRIAZINONE DERIVATIVES AS NLRP3 INHIBITORS"
Published:
May 18, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: ROCHE DIAGNOSTICS GMBH, F. HOFFMANN-LA ROCHE AG, ROCHE MOLECULAR SYSTEMS, INC. FILES APPLICATION FOR "A GRIPPING DEVICE CONFIGURED FOR GRIPPING AT LEAST ONE SLIDE"
Published:
May 18, 2024
by U.S. Fed News
|
Australia Patent: F. HOFFMANN-LA ROCHE, GENENTECH File Application for 'METHODS FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE'
Published:
May 17, 2024
by Australian Government
|
Ask us about our Government & Public Policy market view